OpenAI Moves to Dismiss New York Times Suit, Alleging 'Hack'
By Ben Glickman
OpenAI moved to dismiss a lawsuit from The New York Times Co., alleging the company had paid someone to hack OpenAI's products to support its suit.
The Times is suing OpenAI and Microsoft for alleged copyright infringement. The newspaper has claimed that OpenAI used its content to create artificial intelligence tools and that these tools divert traffic from the Times' website.
The maker of ChatGPT struck back in a court filing, arguing for the dismissal of parts of the case on various grounds. OpenAI said in the filing that certain allegations were more than three years old and the company didn't have actual knowledge of the specific acts of alleged infringements.
OpenAI argued generally that ChatGPT is not a substitute for a New York Times subscription, and that people don't use its products this way.
The company disputed part of the Times' complaint, alleging that the Times had "paid someone to hack OpenAI's products."
OpenAI said that in order to generate responses from the AI tool that exactly matched Times content, the Times made "tens of thousands of attempts" and had to feed ChatGPT portions of articles.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
February 27, 2024 15:50 ET (20:50 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom